The U.S. Court of Appeals for the Federal Circuit in Washington, D.C., has sided with EOFlow in its patent spat with Insulet (Nasdaq:PODD). In its decision, the court overturned a verdict from 2024 that ordered EOFlow to pay nearly $60 million to Insulet. A jury found that EOFlow and several other defendants misappropriated Insulet’s trade secrets […]
Business/Financial News
ViCentra CEO explains how Kaleido can compete with ‘handbrake off,’ increased growth, scale
Since ViCentra closed an $85 million funding round in September 2025, the milestones have continued to stack up. The Dutch automated insulin delivery system developer added a a $13 million extension to that Series D round in January. CEO Tom Arnold outlined the company’s plans for the cash infusion last year, including scaling manufacturing. Today, […]
ViCentra triples manufacturing capacity ahead of Kaleido rollout through Phillips Medisize collab
ViCentra announced today that it began commercial-scale production of its Kaleido insulin pump technology at Phillips Medisize. The Dutch automated insulin delivery system developer said it began production of consumables, including infusion sets and insulin cartridges, with the Molex company — a leading global medical technology contract development and manufacturing organization (CDMO). The collaboration more […]
Abbott wins CE mark for dual glucose-ketone sensor
Abbott (NYSE:ABT) announced today that it received CE mark approval for its dual glucose-ketone sensing technology for people with diabetes. The company said its dual sensor marks a world first, continuously measuring glucose and ketone levels every minute. Branded as Libre Duo and Libre Duo 10 Day, the sensors provide real-time visibility into glucose levels […]
Glucotrack CEO explains tech behind long-term CBGM implant
Glucotrack (Nasdaq:GCTK) has made great strides over the past several years as it advances its implantable continuous blood glucose monitor (CBGM). Rutherford, New Jersey-based Glucotrack’s device features no on-body external component. The company aims to offer it for three years of continuous, accurate blood glucose monitoring for a more convenient, less intrusive solution. Unlike traditional CGMs that […]
Insulet initiates another Omnipod 5 recall affecting 7 million devices including some Dash, Eros systems
Insulet (Nasdaq:PODD) today announced a voluntary medical device correction for specific lots of its Omnipod 5, Dash and Eros pods. The company identified a manufacturing issue through ongoing product monitoring that could result in insulin under-delivery with the affected current-generation Omnipod 5, previous-generation Omnipod Dash or the prior Omnipod Insulin Management System (Eros). Insulet said […]
MiniMed launches MiniMed Go smart multiple daily injection system in US
MiniMed (Nasdaq:MMED) announced today that it began the U.S. launch of MiniMed Go, a connected smart multiple daily injection (MDI) system. The smart MDI system integrates the InPen smart insulin pen with the Instinct sensor made by Abbott. It all integrates within a mobile app to deliver real-time, personalized insights and actionable guidance. The platform targets people […]
Tandem launches t:slim mobile app in trio of European countries
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it made its t:slim mobile app available in a handful of new European countries. The company said on LinkedIn via its International account that it made the app available on both Android and iOS in Germany, Belgium and the Netherlands. San Diego-based Tandem’s t:slim mobile app connects to […]
Dexcom says third party stole, sold scrapped G7 CGM lots
Dexcom (Nasdaq:DXCM) announced today that third parties stole and sold certain G7 continuous glucose monitor (CGM) lots designated as scrap. The company identified the lots — stolen during the destruction process — through ongoing quality and accounting reviews. At this moment, the company reports two G7 lots (1725204004 and 1725069002) as stolen, sold and used by some […]
Beta Bionics earmarks Q2 2027 for Mint patch pump launch, shares details on new tech
Beta Bionics (Nasdaq:BBNX) today provided an update on its expected commercialization timeline for its Mint patch pump system. Irvine, California-based Beta Bionics said it expects to fully commercialize Mint by the end of the second quarter of 2027. This represents an accelerated timeline compared to previous expectations for the end of 2027. The automated insulin […]
